Joseph Thompson Sells 75,000 Shares of Kits Eyecare (TSE:KITS) Stock

Kits Eyecare Ltd (TSE:KITSGet Free Report) insider Joseph Thompson sold 75,000 shares of the firm’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of C$13.65, for a total value of C$1,023,750.00. Following the transaction, the insider directly owned 960,114 shares of the company’s stock, valued at C$13,105,556.10. This represents a 7.25% decrease in their position.

Kits Eyecare Price Performance

Shares of KITS stock opened at C$14.14 on Friday. The company’s 50-day moving average price is C$13.53. Kits Eyecare Ltd has a fifty-two week low of C$10.61 and a fifty-two week high of C$22.56. The company has a market capitalization of C$480.69 million, a PE ratio of 141.40 and a beta of 0.11.

Kits Eyecare (TSE:KITSGet Free Report) last announced its earnings results on Wednesday, May 6th. The company reported C$0.06 earnings per share for the quarter. The firm had revenue of C$57.47 million for the quarter.

Analysts Set New Price Targets

Several research analysts recently weighed in on KITS shares. Canaccord Genuity Group decreased their target price on Kits Eyecare from C$23.00 to C$22.00 and set a “buy” rating for the company in a research note on Thursday, May 7th. ATB Cormark Capital Markets decreased their target price on Kits Eyecare from C$20.00 to C$16.75 and set a “speculative buy” rating for the company in a research note on Thursday, May 7th. Stifel Nicolaus decreased their target price on Kits Eyecare from C$24.00 to C$21.00 and set a “buy” rating for the company in a research note on Thursday, May 7th. Finally, Desjardins decreased their target price on Kits Eyecare from C$25.00 to C$23.00 and set a “buy” rating for the company in a research note on Thursday, May 7th. Four analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of C$20.69.

View Our Latest Stock Analysis on Kits Eyecare

Kits Eyecare Company Profile

(Get Free Report)

KITS (TSX: KITS) is one of the world’s fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.

Further Reading

Receive News & Ratings for Kits Eyecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kits Eyecare and related companies with MarketBeat.com's FREE daily email newsletter.